More on CVRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.39 |
|
|||
| Open | $1.39 | ||||
| 52 Wk High | $0.35 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $1.39 | ||||
| Day Low | $1.26 | ||||
| P/E | N/A | ||||
| EPS | $-0.01 | ||||
| Volume | 382,715 | ||||
- Form SCHEDULE 13D/A CVRx, Inc. Filed by: Chernett Jorey
- CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
- Canaccord Reiterates Buy Rating on CVRx Inc (CVRX)
- Form 8-K CVRx, Inc. For: Sep 16
- CVRx names John Landry as its new chief financial officer
- CVRx Appoints John Landry as Chief Financial Officer
- CVRx board responds to shareholder letter on valuation concerns
- CVRx Responds to Letter from Pointillist Family Office
- Form SCHEDULE 13D CVRx, Inc. Filed by: Chernett Jorey
- CVRx, Inc. Investors Who Suffered Losses Should Contact Block & Leviton LLP
Entities mentioned with CVRX
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- JPMorgan | View Related Stories »
- Canaccord Genuity | View Related Stories »
- IPO | View Related Stories »
- Show More...
